Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-25-086952
Filing Date
2025-09-12
Accepted
2025-09-11 19:16:41
Documents
12
Period of Report
2024-10-18
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea0256995-8ka1_abvcbio.htm   iXBRL 8-K/A 23656
  Complete submission text file 0001213900-25-086952.txt   189756

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abvc-20241018.xsd EX-101.SCH 3020
3 XBRL LABEL FILE abvc-20241018_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE abvc-20241018_pre.xml EX-101.PRE 22362
14 EXTRACTED XBRL INSTANCE DOCUMENT ea0256995-8ka1_abvcbio_htm.xml XML 4376
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

EIN.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40700 | Film No.: 251309678
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)